« Back to Record
Vukusic, S., Brassat, D., de Seze, J., Izquierdo, G., Lysandropoulos, A., Moll, W., Vanopdenbosch, L., Arque, M. J., Kertous, M., Rufi, P., & Oreja-Guevara, C. (2019). Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD). Multiple Sclerosis and Related Disorders, 29, 7-14. doi:10.1016/j.msard.2019.01.019
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/283853



